France
SYNEIKA is a French innovation leader in the Health and Wellness and Manufacturing industries, founded in 2009. Specializing in non-invasive neurostimulation, the company focuses on treating chronic neurological and psychiatric disorders using Transcranial Magnetic Stimulation (TMS). Their slogan, "Treatment of chronic pathologies by non-invasive neurostimulation," encapsulates their commitment to therapeutic advancement.
At the heart of their offerings is Syneika One, a neuronavigator developed in collaboration with medical professionals to optimize precision and usability for care teams. This device supports accessible and efficient TMS therapy through advanced algorithms and a streamlined patient registration workflow. SYNEIKA operations adhere to the quality standards of EN ISO 13485, ensuring high reliability of their medical devices.
Currently, there is no available data on their last investment or investors, perhaps indicating an opportunity for new investments to further scale this promising venture.
